Our mission, corporative objectives
To research and develop immunotherapies and diagnostic methods used in the treatment of degenerative diseases. It is our aim to provide effective solutions for such diseases.
Within the area of degenerative diseases, we are currently focused on Alzheimer’s disease. As such, our initial objectives are:
- Validation and global marketing of a diagnostic blood test for Alzheimer’s disease.
- Development of effective immunotherapy against Alzheimer’s disease.